FDA Grants Accelerated Approval To Iberdomide With Daratumumab And Hyaluronidase-Fihj And Dexamethasone For Multiple Myeloma
BMY•FDA accelerated approval announcement
Aug. 13 (Reuters) - Bristol-Myers Squibb Company BMY.N:
- FDA grants accelerated approval to iberdomide with daratumumab and hyaluronidase-fihj and dexamethasone for multiple myeloma
